| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +66.67% | +73.09% | -2.61% | +75.70% | -8.87% | — |
| 14d | 3 | +100.00% | +100.16% | -2.87% | +103.03% | +7.57% | — |
| 30d | 3 | +100.00% | +99.74% | -2.70% | +102.44% | +1.60% | — |
| 60d | 3 | +66.67% | +83.05% | -4.74% | +87.80% | -0.05% | — |
| 90d | 3 | +66.67% | +85.30% | -0.60% | +85.90% | +4.64% | — |
| 180d | 3 | +33.33% | +170.44% | +2.28% | +168.16% | +20.00% | — |
| 1y | 3 | +66.67% | +293.88% | +17.77% | +276.12% | -21.30% | — |
| 2y | 3(1 pending) | +100.00% | +308.24% | +29.75% | +278.50% | +278.50% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 375,000 | — | — | 375,000 | Jun 25, 2026 | Jun 29, 2026 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Jun 5, 2025 | Jun 9, 2025 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE PRESIDENT & CEO | 11,500 | $26.82 | $308.4K | 40,284 | Nov 11, 2024 | Nov 12, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Jun 13, 2024 | Jun 17, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Jun 15, 2023 | Jun 20, 2023 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE PRESIDENT & CEO | 75,000 | $2.78 | $208.5K | 102,692 | Aug 15, 2022 | Aug 17, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE PRESIDENT & CEO | 75,000 | — | — | 25,000 | Aug 15, 2022 | Aug 17, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE PRESIDENT & CEO | 45,000 | — | — | 26,665 | Aug 15, 2022 | Aug 17, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE PRESIDENT & CEO | 45,000 | $9.02 | $405.7K | 147,692 | Aug 15, 2022 | Aug 17, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE PRESIDENT & CEO | 120,000 | $37.66 | $4.52M | 27,692 | Aug 15, 2022 | Aug 17, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Jun 16, 2022 | Jun 17, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE President & CEO | 3,537 | $42.00 | $148.6K | 27,231 | Aug 5, 2021 | Aug 9, 2021 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE President & CEO | 3,537 | — | — | 0 | Aug 5, 2021 | Aug 9, 2021 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 224,000 | — | — | 224,000 | Jun 17, 2021 | Jun 21, 2021 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 245,000 | — | — | 245,000 | Jun 18, 2020 | Jun 19, 2020 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE President & CEO | 15,000 | $3.06 | $45.9K | 19,438 | Jun 9, 2020 | Jun 10, 2020 ↗ | View → |